The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach

Current Nutrition Reports

Volumn 2, Issue 1, 2013, Pages 19-26

  Weijenberg, Matty P ^a   Hughes, Laura A E ^a   Bours, Martijn J L ^a   Simons, Colinda C J M ^a   van Engeland, Manon ^a   van den Brandt, Piet A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adolescent; Cancer prognosis; Cancer risk; Cancer survivor; Childhood; Colon; Diet; Dietary protein; Elderly; Energy balance; Energy restriction; Epigen; Etiology; Molecular epidemiology; mTOR pathway; Neoplasm; Obesity; Overweight; Physical activity; Rectum; Sarcopenia

Indexed keywords

BIOLOGICAL MARKER; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN; SOMATOMEDIN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; BLADDER CANCER; CALORIC RESTRICTION; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CHILDHOOD OBESITY; COLORECTAL CANCER; ENERGY BALANCE; EXPOSURE; GENETIC VARIABILITY; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MUSCLE ATROPHY; NONHUMAN; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EID: 84892438835     PISSN: None     EISSN: 21613311     Source Type: Journal    
DOI: 10.1007/s13668-012-0038-7     Document Type: Review

References (82)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AIRC; 2007.
2. •• Hursting SD, Digiovanni J, Dannenberg AJ, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res. 2012; 5: 1260-72. This article provides a description of mechanisms that underlie the obesity-cancer relationships and discusses opportunities for primary to tertiary prevention.
3. Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol. 2012; 30: 3697-704.
4. Slattery ML, Fitzpatrick FA. Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res. 2009; 2: 922-30.
5. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011; 23: 744-55.
6. •• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012; 149: 274-93. This is another review on the mechanisms linking mTOR signaling to various diseases and discussing pharmacological approaches.
7. •• Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12: 21-35. This article features a comprehensive review of mTOR regulators, the action of mTOR and its role in cancer, diabetes and ageing.
8. Campbell PT, Jacobs ET, Ulrich CM, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010; 102: 391-400.
9. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007; 13: 4199-206.
10. Hughes LA, Simons CC, van den Brandt PA, et al. Body size and colorectal cancer risk after 16. 3 years of follow-up: an analysis from the Netherlands Cohort Study. Am J Epidemiol. 2011; 174: 1127-39.
11. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev. 2010; 11: 19-30.
12. Oxentenko AS, Bardia A, Vierkant RA, et al. Body size and incident colorectal cancer: a prospective study of older women. Cancer Prev Res. 2010; 3: 1608-20.
13. Wang Y, Jacobs EJ, Patel AV, et al. A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Cancer Causes Control. 2008; 19: 783-92.
14. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007; 86: 556-65.
15. Harriss DJ, Atkinson G, George K, et al. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis. 2009; 11: 547-63.
16. Moradi T, Gridley G, Bjork J, et al. Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. Eur J Cancer Prev. 2008; 17: 201-8.
17. Nilsen TI, Romundstad PR, Petersen H, et al. Recreational physical activity and cancer risk in subsites of the colon (the Nord-Trondelag Health Study). Cancer Epidemiol Biomark Prev. 2008; 17: 183-8.
18. Parent ME, Rousseau MC, El-Zein M, et al. Occupational and recreational physical activity during adult life and the risk of cancer among men. Cancer Epidemiol. 2011; 35: 151-9.
19. Spence RR, Heesch KC, Brown WJ. A systematic review of the association between physical activity and colorectal cancer risk. Scand J Med Sci Sports. 2009; 19: 764-81.
20. Wolin KY, Lee IM, Colditz GA, et al. Leisure-time physical activity patterns and risk of colon cancer in women. Int J Cancer. 2007; 121: 2776-81.
21. Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009; 100: 611-6.
22. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-91.
23. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006; 98: 920-31.
24. Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008; 67: 128-45.
25. Dirx MJ, van den Brandt PA, Goldbohm RA, et al. Diet in adolescence and the risk of breast cancer: results of the Netherlands Cohort Study. Cancer Causes Control. 1999; 10: 189-99.
26. Dirx MJ, van den Brandt PA, Goldbohm RA, et al. Energy restriction in childhood and adolescence and risk of prostate cancer: results from the Netherlands Cohort Study. Am J Epidemiol. 2001; 154: 530-7.
27. Dirx MJ, van den Brandt PA, Goldbohm RA, et al. Energy restriction early in life and colon carcinoma risk: results of The Netherlands Cohort Study after 7. 3 years of follow-up. Cancer. 2003; 97: 46-55.
28. Elias SG, Peeters PH, Grobbee DE, et al. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. J Natl Cancer Inst. 2004; 96: 539-46.
29. Hughes LA, van den Brandt PA, Goldbohm RA, et al. Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort Study. Int J Epidemiol. 2010; 39: 1333-44.
30. Schouten LJ, van Dijk BA, Lumey LH, et al. Energy restriction during childhood and early adulthood and ovarian cancer risk. PLoS One. 2011; 6: e27960.
31. Svensson E, Grotmol T, Hoff G, et al. Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis. Eur J Cancer Prev. 2002; 11: 489-95.
32. Svensson E, Moller B, Tretli S, et al. Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control. 2005; 16: 215-23.
33. Hursting SD, Lavigne JA, Berrigan D, et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med. 2003; 54: 131-52.
34. Moore T, Beltran L, Carbajal S, et al. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res. 2008; 1: 65-76.
35. Kritchevsky D. Colorectal cancer: the role of dietary fat and caloric restriction. Mutat Res. 1993; 290: 63-70.
36. Kritchevsky D, Klurfeld DM. Influence of caloric intake on experimental carcinogenesis: a review. Adv Exp Med Biol. 1986; 206: 55-68.
37. Weindruch R, Albanes D, Kritchevsky D. The role of calories and caloric restriction in carcinogenesis. Hematol Oncol Clin N Am. 1991; 5: 79-89.
38. Hughes LA, van den Brandt PA, de Bruine AP, et al. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS One. 2009; 4: e7951.
39. Nimptsch K, Giovannucci E, Willett WC, et al. Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res. 2011; 4: 1710-8.
40. Okasha M, Gunnell D, Holly J, et al. Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab. 2002; 16: 225-41.
41. Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011; 12: 785-94.
42. Jacobsen PB, Jim HS. Consideration of quality of life in cancer survivorship research. Cancer Epidemiol Biomark Prev. 2011; 20: 2035-41.
43. Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011; 105 suppl 1: S52-73.
44. •• Demark-Wahnefried W, Platz EA, Ligibel JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012; 21: 1244-59. This article summarizes the discussion of a workshop and covers mechanisms, complexities of studying and interpreting observational and intervention research and discusses future directions.
45. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2012; 92: 471-90.
46. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008; 11: 693-700.
47. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012; 31: 583-601.
48. Walker DK, Dickinson JM, Timmerman KL, et al. Exercise, amino acids, and aging in the control of human muscle protein synthesis. Med Sci Sports Exerc. 2011; 43: 2249-58.
49. Chen J. Multiple signal pathways in obesity-associated cancer. Obes Rev. 2011; 12: 1063-70.
50. Hall MN. mTOR-what does it do? Transplant Proc. 2008; 40: S5-8.
51. Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010; 5: e9199.
52. Campa D, Husing A, Stein A, et al. Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). PLoS One. 2011; 6: e16914.
53. Azim H, Azim Jr HA, Escudier B. Targeting mTOR in cancer: renal cell is just a beginning. Target Oncol. 2010; 5: 269-80.
54. Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008; 27: 5497-510.
55. Gulhati P, Bowen KA, Liu J, et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011; 71: 3246-56.
56. Gulhati P, Cai Q, Li J, et al. Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer. Clin Cancer Res. 2009; 15: 7207-16.
57. Moore T, Checkley LA, DiGiovanni J. Dietary energy balance modulation of epithelial carcinogenesis: a role for IGF-1 receptor signaling and crosstalk. Ann N Y Acad Sci. 2011; 1229: 7-17.
58. Hursting SD, Lashinger LM, Wheatley KW, et al. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab. 2008; 22: 659-69.
59. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001; 131: 3109S-20S.
60. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001; 60: 91-106.
61. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005; 97: 1679-87.
62. Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol. 2004; 167: 399-403.
63. Jiang W, Zhu Z, Thompson HJ. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res. 2008; 68: 5492-9.
64. Weigl LG. Lost in translation: regulation of skeletal muscle protein synthesis. Curr Opin Pharmacol. 2012; 12: 377-82.
65. Sakuma K, Yamaguchi A. Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci. 2010; 3: 90-101.
66. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signaling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care. 2008; 11: 222-6.
67. Dickinson JM, Fry CS, Drummond MJ, et al. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. J Nutr. 2011; 141: 856-62.
68. Zhang ZJ, Zheng ZJ, Kan H, et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2011; 34: 2323-8.
69. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer-beyond physical activity. Cancer Res. 1997; 57: 75-80.
70. Lin J, Wang J, Greisinger AJ, et al. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res (Phila). 2010; 3: 505-17.
71. Morois S, Mesrine S, Josset M, et al. Anthropometric factors in adulthood and risk of colorectal adenomas: the French E3N-EPIC prospective cohort. Am J Epidemiol. 2010.
72. Kokubo T, Kakinuma S, Kobayashi T, et al. Age dependence of radiation-induced renal cell carcinomas in an Eker rat model. Cancer Sci. 2010; 101: 616-23.
73. De Angel RE, Conti CJ, Wheatley KE, et al. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. Mol Carcinog. 2012.
74. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334: 105-8.
75. De Fellipo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci. 2010; 107: 14691-6.
76. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2010; 60: 397-411.
77. Le Marchand L, Wilkens LR. Design considerations for genomic association studies: importance of gene-environment interactions. Cancer Epidemiol Biomark Prev. 2008; 17: 263-7.
78. Slattery ML, Herrick JS, Lundgreen A, et al. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis. 2010; 31: 1604-11.
79. Chen M, Cassidy A, Gu J, et al. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009; 30: 2047-52.
80. Hughes LA, Williamson EJ, van Engeland M, et al. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol. 2012; doi: 10. 1093/ije/dys055.
81. Ogino S, Giovannucci E. Commentary: lifestyle factors and colorectal cancer microsatellite instability-molecular pathological epidemiology science, based on unique tumor principle. Int J Epidemiol. 2012. doi: 10. 1093/ije/dys076.
82. Nogueira LM, Dunlap SM, Ford NA, et al. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity. Endocr Relat Cancer. 2012; 19: 57-68.